Fortrea Holdings Inc. (FTRE) Key Metrics

NASDAQ: FTREValuation, returns, debt and efficiency ratios over 6 years.

FTRE valuation today

Trailing 12 months · as of October 17, 2026
Market cap
$2.14B
Enterprise value
$2.81B
P/E (TTM)
—
Forward P/E
12.1
PEG ratio
0.34
Price / sales
0.8
10-yr median 0.6
Price / book
3.5
10-yr median 1.8
EV / EBITDA
33.1
Dividend yield
—
Beta
1.91

FTRE key metrics, 2020–2025

Fiscal year ended December 31, 2025 · U.S. dollars

FTRE valuation Price multiples at each fiscal year-end price.

Price / sales−6.7%
0.6
2025 · hover or tap a bar for each year
2023: 1.12024: 0.6 (−43.2%)2025: 0.6 (−6.7%)
20202025
Price / book+127.9%
2.8
2025 · hover or tap a bar for each year
2023: 1.82024: 1.2 (−32.2%)2025: 2.8 (+127.9%)
20202025
Price / free cash flow+153.3%
17.8
2025 · hover or tap a bar for each year
2023: 24.22024: 7.0 (−70.9%)2025: 17.8 (+153.3%)
20202025
Free cash flow yield−8.6 pts
5.6%
2025 · hover or tap a bar for each year
2023: 4.1%2024: 14.2% (+10.1 pts)2025: 5.6% (−8.6 pts)
20202025

FTRE valuation history

Fiscal year-endToday6-year median

FTRE returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

FTRE debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

FTRE price vs earnings per share

Share price at year-endEPS (right axis)

FTRE key metrics

2020–2025
Fortrea Holdings Inc. key metrics by fiscal year
202520242023202220212020
Valuation
Market capitalization$1.57B$1.67B$3.10B———
Enterprise value$2.51B$2.75B$4.66B———
Price / sales0.60.61.1———
Price / book2.81.21.8———
Price / free cash flow17.87.024.2———
Price / operating cash flow13.96.418.4———
EV / sales0.91.01.6———
EV / EBITDA——34.0———
EV / free cash flow28.511.636.4———
Earnings yield−62.7%−19.7%−0.8%———
Free cash flow yield5.6%14.2%4.1%———
Share price at fiscal year-end$17.25$18.65$34.90———
Per share
Revenue per share$29.86$30.13$32.01$32.09$34.59$29.19
Earnings per share−$10.81−$3.67−$0.28$2.11$1.11−$4.06
Operating cash flow per share$1.24$2.94$1.90$0.94$1.92$2.27
Free cash flow per share$0.97$2.65$1.44$0.32$1.62$2.00
Cash per share$1.91$1.32$1.22$1.27$1.07—
Book value per share$6.18$15.22$19.30$37.81$36.88—
Tangible book value per share−$11.17−$11.21−$8.48$5.90$2.76—
Capex per share$0.28$0.28$0.45$0.62$0.30$0.27
Debt per share$12.24$13.39$18.83$0.72$0.87—
Shares outstanding91.2M89.5M88.8M88.4M88.4M88.4M
Change in shares outstanding+1.9%+0.8%+0.5%0.0%0.0%—
Returns & profitability
Return on equity (ROE)−102.4%−21.4%−1.0%5.6%3.0%—
Return on invested capital (ROIC)−1.2%−4.5%0.8%4.5%2.5%—
Return on assets (ROA)−31.3%−8.3%−0.6%4.3%2.2%—
Return on tangible assets−87.0%−27.1%−1.4%12.7%7.2%—
Free cash flow margin3.2%8.8%4.5%1.0%4.7%6.9%
Income quality (OCF / net income)———0.441.73—
Financial health
Total debt$1.12B$1.20B$1.67B$63.4M$77.2M—
Cash & short-term investments$174.6M$118.5M$108.6M$112.0M$94.6M—
Net debt$941.4M$1.08B$1.56B−$48.6M−$17.4M—
Debt / equity1.980.880.980.020.02—
Debt / assets0.410.330.390.010.02—
Net debt / EBITDA——11.40−0.17−0.06—
Current ratio0.981.001.611.781.35—
Quick ratio0.981.001.561.781.35—
Interest coverage-0.3-1.30.5935.5571.5—
Working capital−$16.1M−$1.3M$472.4M$547.9M$290.8M—
Invested capital$1.50B$2.44B$3.28B$3.29B$3.24B—
Tangible asset value−$1.02B−$1.00B−$753.4M$522.0M$244.2M—
Net current asset value−$1.25B−$1.27B−$1.37B$301.6M$9.4M—
Graham number———$42.33$30.33—
Graham net-net per share−$16.59−$17.63−$19.53−$0.51−$3.41—
Capital allocation
Capex / revenue0.9%0.9%1.4%1.9%0.9%0.9%
Capex / operating cash flow22.2%9.7%23.9%65.8%15.6%11.9%
Capex / depreciation0.320.290.410.580.160.20
Stock-based compensation / revenue2.7%2.2%1.5%0.9%0.9%0.9%
SG&A / revenue16.8%20.8%11.8%10.6%9.9%10.4%
Efficiency
Days sales outstanding88.1115.4132.4128.7113.4—
Days of inventory on hand——5.7———
Days payables outstanding13.322.917.412.39.0—
Cash conversion cycle (days)74.792.5120.7116.5104.4—
Receivables turnover4.153.162.762.843.22—
Payables turnover27.3715.9521.0129.7540.55—
Inventory turnover——63.79———
Asset turnover0.870.680.660.660.70—
Average receivables$657.0M$852.2M$1.03B$1.00B$949.8M—
Average payables$84.0M$135.6M$107.2M$71.0M$60.5M—
Average inventory——$35.3M———
Intangibles / total assets58.3%66.1%57.0%65.8%69.0%—

Computed from FTRE's annual financial statements (latest annual report filed February 26, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

FTRE valuation and financial ratios

Fortrea earned a return on equity of −102.4% and a return on invested capital of −1.2% in fiscal 2025. It ended the year with $1.1 billion of debt and $174.6 million in cash and short-term investments, net debt of $941.4 million. The share count rose 3.2% from 88.4M to 91.2M over 5 years.

See the FTRE income statement, the FTRE chart for price history, or the FTRE stock overview for the latest quote and news.

FTRE key metrics FAQ

What is Fortrea's return on equity?

Fortrea's return on equity (ROE) was −102.4% in fiscal 2025: net income of -$986.2 million on average shareholders' equity of $963.0 million.

What is Fortrea's ROIC?

Fortrea's return on invested capital was −1.2% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Fortrea have?

Fortrea had total debt of $1.1 billion at the end of fiscal 2025, a debt-to-equity ratio of 1.98.

What is Fortrea's free cash flow yield?

Fortrea generated $88.3 million of free cash flow in fiscal 2025, a free cash flow yield of 5.6% on its market value at year-end ($1.6 billion).

What is Fortrea's current ratio?

Fortrea's current ratio was 0.98 at the end of fiscal 2025: current assets were 0.98 times current liabilities.

Biotechnology key metrics